The usage of personalized scheme of fentanyl administration during coronary artery stenting

D.О. Dziuba

References  

1. Dziuba DО, Byshovets SM, Loskutov OA. Establishing the optimal depth of analgesia during coronary artery stenting. Pain, Anaesthesia and Intensive Care. 2020;3 (92):17–24. doi: 10.25284/2519-2078.3(92).2020.211432.
2. Dziuba , Zhurovska UM, Loskutov OA. Issues of anesthesia in interventional cardiology. Emergency Medicine. 2017;1(80):125–128. doi: 10.22141/2224-0586.1.80.2017.94464.
3. Zozulia IS, Zozulia AI. Epidemiology of cerebrovascular diseases in Ukraine. Ukr. Med. J. 2011;5:38–41.
4. Kozlov AI, Kozlova MA. Cortisol as a marker of stress. Human physiology. 2014;40:123–123. doi: 10.7868/S013116461402009X.
5. Armario A, Marti O, Molina T, de Pablo J, Valdes M. Acute stress markers in humans: response of plasma glucose, cortisol and prolactin to two examinations differing in the anxiety they provoke. Psychoneuroendocrinology. 1996;21(1):17–24. doi: 10.1016/0306-4530(95)00048-8.
6. Benjamin EJ, Virani SS, Callaway CW. et al. Heart disease and stroke statistics – 2018 update: A Report From the American Heart Association. Circulation. 2018;137(12):67–492. doi: 10.1161/CIR.0000000000000558.
7. Burns SM, Cunningham, CW, Mercer SL. DARK classics in chemical neuroscience: fentanyl. ACS Chemical Neuroscience. 2018;9(10):2428–2437. doi: 10.1021/acschemneuro.8b00174.
8. Choi L, Ferrell BA. Vasilevskis EE. et al. Population pharmacokinetics of fentanyl in the critically ill. Critical Care Medicine. 2016;44(1):64. doi: 10.1097/CCM.0000000000001347.
9. Dong H, Zhang FJ, Wang FY, Wang YY, Guo J, Kanhar GM, ... Chen X. Simultaneous on-line monitoring of propofol and sevoflurane in balanced anesthesia by direct resistive heating gas chromatography. J Chromatography. 2017;1506:93–100. https://doi.org/10.1016/j.chroma.2017.05.001.
10. Drummer OH. Fatalities caused by novel opioids: a review. Forensic Sci Res. 2019;4(2) :95–110. doi: 10.1080/20961790.2018.1460063.
11. Hagos FT, Horvat CM, Au AK, Conley YP, Li L, Poloyac SM, Kochanek PM, Clark RSB, Empey PE Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children. Clin Pharmacokinet. 2019;58:1567–1576. doi: 10.1007/s40262-019-00773-1.
12. Haslam PJ, Yap B, Mueller PR, Lee MJ. Anesthesia practice and clinical trends in interventional radiology: a European survey. Cardiovasc Interven Radiology. 2000;23(4):256–261. doi: 10.1007/s002700010065.
13. Koolen SL, Van der Rijt CC. Is there a role for pharmacogenetics in the dosing of fentanyl? Pharmacogenomics. 2017;18(5):417–419. doi: 10.2217/pgs-2017-0022.
14. Michael ML, Lennox PH. Sedation and analgesia in the interventional radiology department. J Vasc Interv Radiology. 2003;14 (9):1119–1128.
15. Movsisyan NK, Vinciguerra M, Medina-Inojosa JR, Lopez-Jimenez F. Cardiovascular Diseases in Central and Eastern Europe: A Call for Morge Surveillance and Evidence-Based Health Promotion. Annals of Global Health. 2020;86(1).
16. Mueller PR, Wittenberg KH, Kaufman JA, Lee MJ. Patterns of anesthesia and nursing care for interventional radiology proceggdures: a national survey of physician practices and preferences.. Radiology. 1997;202(2):339–343. doi: 10.1148/radiology.202.2.9015053.
17. Norman E, Kindblom JM, Rane A. et al. Individual variations in fentanyl pharmacokinetics and pharmacodynamics in preterm infants. Acta Paediatrica. 2019;108(8):1441–1446. doi: 10.1111/apa.14744.
18. Schifano F, Chiappini S, Corkery JM, Guirguis A. Assessing the 2004–2018 fentanyl misusing issues reported to an international range of adverse reporting systems. Front Pharmacology. 2019. doi: 10.3389/fphar.2019.00046.
19. Schug SA, Ting S. Fentanyl formulations in the management of pain: an update. Drugs. 2017;77(7):747–763. doi: 10.1007/s40265-017-0727-z.
20. Sekhri NK, Cooney MF. Opioid metabolism and pharmacogenetics: clinical implications. J Peri Anesthesia Nursing. 2017;32(5):497–505. doi: 10.1016/j.jopan.2017.07.005.
21. Smith HS, Laufer A. Opioid induced nausea and vomiting. Eur J Pharmacology. 2014;722:67–78. doi: 10.1016/j.ejphar.2013.09.074.
22. Solhaug V, Molden E. Individual variability in clinical effect and tolerability of opioid analgesics – importance of drug interactions and pharmacogenetics. Scandinavian J Pain. 2017;17(1):193–200. doi: 10.1016/j.sjpain.2017.09.009.
23. Vari A, Gangi A. Anesthesia practices for interventional radiology in Europe. Cardiovasc Intervent Radiology. 2017;40:803–813. doi: 10.1007/s00270-017-1576-6.
24. Versaci F, Gaspardone A, Tomai F, Proietti I, Crea F, Chiariello L, Gioffrè PA. Chest pain after coronary artery stent implantation. Amer J Cardiology. 2002;89(5):500–504. doi: 10.1016/s0002-9149(01)02287-1.
25. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR. et al. Heart disease and stroke statistics 2020 update: a report from the American Heart Association. Circulation. 2020;141:E139–E596. doi: 10.1161/CIR.0000000000000757.
26. Yiannakopoulou E. Pharmacogenomics and opioid analgesics: clinical implications. Intern J Genomics. 2015;2015. doi: 10.1155/2015/368979.
27. Zawilska JB. An expanding world of novel psychoactive substances: opioids. Front Psychiatry. 2017;8:110. doi: 10.3389/fpsyt.2017.00110.

[PDF] [Contents]